Ad
related to: national institute on drug abuse- Fast-Licensed-Certificate for Court MIP-Drug & Alcohol Awareness Course
Legislation, not nuisance-based litigation, is the best solution to the opioid epidemic
The Washington Times· 5 days agoLost in the shadow of the worldwide battle against the COVID-19 pandemic has been America’s fight...
Biden DOJ slow to act on opioid crisis despite AG Garland saying it should be 'high priority'
Fox News· 5 days agoAttorney General Merrick Garland pledged to make the opioid crisis still plaguing America a "high...
Cannabis almost as addictive as opioids among teens, study finds | Post Bulletin
Post-Bulletin· 5 days agoThe rates of addiction were significant, especially since teenagers’ brains are still developing,...
11% of teens who try marijuana report they are dependent a year later, national study says
NJ.com· 7 days agoBy year three, 20% had developed a substance abuse disorder, according to the research paper...
Missouri legislators try to pass prescription monitoring database bill for the tenth time
KOMU Columbia· 4 days agoMissouri is the only state without a database that monitors prescription drugs given to patients,...
Have you seen me: TV6 Investigates looks into disappearance of David McAllister
KWQC-TV 6 Davenport· 4 days agoAccording to the Quad Cities Missing Persons Network, 25 people have gone missing in the QCA since...
While New York Legalizes Cannabis, Cornell Keeps Long-Standing Restrictions
The Cornell Daily Sun· 5 days agoWeed, grass, the “devil’s lettuce” — whatever students call it, adult recreational use of cannabis...
This Heroin-Using Professor Wants to Change How We Think About Drugs
New York Times· 3 days agoProf. Carl Hart saw drugs as destroyers of communities. Carl L. Hart, a neuroscientist at Columbia...
Claremont police shooting spurs questions of training, resources for situations involving mental...
Valley News· 2 days agoFollowing Jeffrey Ely’s death in a police shooting late last month, friends and Upper Valley mental...
Opiant Pharma's Starts Dosing In Nasal Nalmefene Comparison Study For Remifentanil-Related...
Benzinga· 7 days agoOpiant Pharmaceuticals Inc (NASDAQ: OPNT) has dosed the first subjects in a head-to-head clinical study comparing the effectiveness of its investigational...
